RxDoctor Payments Data

Kumarasamy Sivakumar

Internal Medicine · Lancaster, CANPI 1083762884

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Novo Nordisk at 25.6% of the total. Reporting peaked in 2020 at $1,007 and has fallen 58.1% since, to $422 in 2021.

$1,921in general payments, 2019–2025

Across 109 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$492
  • AbbVie$225
  • GSK$199
  • Amgen$153
  • Avanir Pharmaceuticals, Inc.$130
  • Ironwood Pharmaceuticals, Inc$126
  • plus $595 from 13 others

What the payments were for

  • Food & beverage$1,921100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,921 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in Lancaster

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →